Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) decreased to $62.22. It was posted on Mar, 12 by Barchart.com. The company has $1.32B market cap. The valuation of NASDAQ:TRHC can change by $92.05 million if our $57.86 price target is reached.

On May, 14 Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)’s earnings release is awaited by WallStreet, as reported by Faxor. This could hit $1.06 million profit for TRHC assuming the current $0.05 EPS will become reality. Wall Street now predicts 0.00 % EPS growth despite Tabula Rasa HealthCare, Inc. last quarter’s EPS of $0.05.

For more Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) news posted briefly go to: Globenewswire.com, Profitconfidential.com, Globenewswire.com, Globenewswire.com or Globenewswire.com. The titles are as follows: “Tabula Rasa HealthCare’s CareKinesis Division Successfully Launched Medication Risk Management and Pharmacy Services for Rocky Mountain PACE – GlobeNewswire” posted on October 30, 2018, “TRHC Stock: Leading in the Medication Safety Space – Profit Confidential” on January 28, 2019, “TRHC and Landmark Announce Expansion of MedWise Medication Risk Mitigation Study – GlobeNewswire” with a publish date: November 08, 2018, “Tabula Rasa HealthCare Announces Proposed Offering of Common Stock – GlobeNewswire” and the last “Tabula Rasa HealthCare Subsidiary CareKinesis is Exclusive Provider of In-Home Medication Reminder Device for PACE Organizations – GlobeNewswire” with publication date: April 16, 2018.

Tabula Rasa HealthCare, Inc. provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to enhance patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk.The firm is worth $1.32 billion. The Company’s cloud software applications include EireneRx, which is used by at-risk healthcare organizations to access its patients' medication-related information; MedWise Advisor that allows for components of EireneRx to be used independently and by a broader healthcare audience; and NiaRx, an educational software platform used in the pharmacy educational community.Last it reported negative earnings. The firm offers its technology-enabled services and products for medication risk management and risk adjustment.